{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:32:50Z","timestamp":1773664370905,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.ejphar.2004.03.050","type":"journal-article","created":{"date-parts":[[2004,6,3]],"date-time":"2004-06-03T12:31:05Z","timestamp":1086265865000},"page":"123-130","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacological characterization of dihydromorphine, 6-acetyldihydromorphine and dihydroheroin analgesia and their differentiation from morphine"],"prefix":"10.1016","volume":"492","author":[{"given":"Annie-Kim","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandor","family":"Hosztafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loriann","family":"Mahurter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavril W","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.03.050_BIB1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-5793(94)01129-X","article-title":"Expression of two variants of the human \u03bc opioid receptor mRNA in SK-N-SH cells and human brain","volume":"354","author":"Bare","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-5793(97)00710-2","article-title":"3-Methoxynaltrexone, a selective heroin\/morphine-6\u03b2-glucuronide antagonist","volume":"412","author":"Brown","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB3","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB4","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"Strategies to manage the adverse effects of oral morphine: an evidence-based report","volume":"19","author":"Cherny","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB6","first-page":"235","article-title":"Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition","volume":"10","author":"Chou","year":"1974","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB7","first-page":"308","article-title":"Opiate binding in calf thalamic membranes: a selective mu1 binding assay","volume":"34","author":"Clark","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB8","first-page":"461","article-title":"Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa1 subtypes and a novel kappa3 subtype","volume":"251","author":"Clark","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB9","first-page":"174","article-title":"A method for determining loss of pain sensation","volume":"72","author":"D'Amour","year":"1941","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB10","first-page":"23","article-title":"A splice variant of the mu opioid receptor is present in human SHSY-5Y cells","author":"Du","year":"1997","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/cpt1971125806","article-title":"Actions and metabolism of heroin administered by continuous intravenous infusion to man","volume":"12","author":"Elliott","year":"1971","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3940(83)90164-7","article-title":"Multiple mu receptors: evidence for mu2 sites in the guinea pig ileum","volume":"39","author":"Gintzler","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB13","series-title":"Analgesics: Pharmacological and Clinical Perspectives","first-page":"69","article-title":"Multiple opiate receptors","author":"Goodman","year":"1984"},{"key":"10.1016\/j.ejphar.2004.03.050_BIB14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1523\/JNEUROSCI.02-05-00572.1982","article-title":"Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines","volume":"2","author":"Hahn","year":"1982","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB15","first-page":"12","article-title":"Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3181\/00379727-218-44301","article-title":"Heroin acts on delta opioid receptors in the brain of streptozocin-induced diabetic rats","volume":"218","author":"Holmes","year":"1998","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB18","first-page":"709","article-title":"Disposition and effects of heroin in pain patients","volume":"9","author":"Inturrisi","year":"1985","journal-title":"Adv. Pain Res. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0024-3205(83)90616-1","article-title":"Evidence from opiate binding sites that heroin acts through its metabolites","volume":"3","author":"Inturrisi","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB20","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1073\/pnas.90.11.5162","article-title":"Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor","volume":"90","author":"Kolesnikov","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1021\/jm00299a003","article-title":"Structure\u2013activity correlations of morphine-like analgetics based on efficiencies following intravenous and intraventricular application","volume":"13","author":"Kutter","year":"1970","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.7361110","article-title":"Absence of cross-tolerance to heroin in morphine-tolerant mice","volume":"206","author":"Lange","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2004.03.050_BIB23","first-page":"13","article-title":"Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice","volume":"224","author":"Lange","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB24","first-page":"597","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1126\/science.6541807","article-title":"Separation of morphine analgesia from physical dependence","volume":"226","author":"Ling","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2004.03.050_BIB26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0006-8993(83)91376-8","article-title":"Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites","volume":"271","author":"Ling","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB27","first-page":"149","article-title":"Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms","volume":"232","author":"Ling","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB28","first-page":"99","article-title":"A simplified method of evaluating dose\u2013effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB29","first-page":"388","article-title":"A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in post-addicts","volume":"133","author":"Martin","year":"1961","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1124\/mol.56.2.396","article-title":"Identification and characterization of three new alternatively spliced mu opioid receptor isoforms","volume":"56","author":"Pan","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0014-5793(00)01095-4","article-title":"Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F","volume":"466","author":"Pan","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB32","doi-asserted-by":"crossref","first-page":"14084","DOI":"10.1073\/pnas.241296098","article-title":"Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene","volume":"98","author":"Pan","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-6147(00)01616-3","article-title":"Incomplete cross tolerance and multiple mu opioid peptide receptors","volume":"22","author":"Pasternak","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB34","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1021\/jm00180a019","article-title":"Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones","volume":"23","author":"Pasternak","year":"1980","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/253563a0","article-title":"Identification of a novel high affinity opiate receptor binding in rat brain","volume":"253","author":"Pasternak","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2004.03.050_BIB37","first-page":"735","article-title":"Opiate receptor binding: enzymatic treatments and discrimination between agonists and antagonists","volume":"11","author":"Pasternak","year":"1975","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB38","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0165-6147(00)89068-9","article-title":"Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology","volume":"16","author":"Pasternak","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB35","first-page":"478","article-title":"Selective enhancement of [3H]opiate agonist binding by divalent cations","volume":"11","author":"Pasternak","year":"1975","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB39","first-page":"340","article-title":"Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists","volume":"11","author":"Pasternak","year":"1975","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0014-2999(88)90680-2","article-title":"Differential blockade by naloxonazine of two m opiate actions: analgesia and inhibition of gastrointestinal transit","volume":"149","author":"Paul","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB41","first-page":"477","article-title":"Pharmacological characterization of morphine-6\u03b2-glucuronide, a very potent morphine metabolite","volume":"251","author":"Paul","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB42","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.182.4119.1359","article-title":"Opiate agonists and antagonists discriminated by receptor binding in brain","volume":"182","author":"Pert","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2004.03.050_BIB43","first-page":"67","article-title":"Receptor binding of 3H-naloxone benzoylhydrazone: a reversible kappa and slowly dissociable \u03bc opiate","volume":"35","author":"Price","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB47","first-page":"448","article-title":"Heroin acts on different opioid receptors than morphine in Swiss\u2013Webster and ICR mice to produce antinociception","volume":"256","author":"Rady","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB44","first-page":"1222","article-title":"The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss\u2013Webster mice","volume":"268","author":"Rady","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB48","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0024-3205(94)00486-2","article-title":"Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss Webster mice","volume":"55","author":"Rady","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB45","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1254\/jjp.78.443","article-title":"Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice","volume":"78","author":"Rady","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB51","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0014-5793(95)00757-Z","article-title":"Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6\u03b2-glucuronide receptor","volume":"369","author":"Rossi","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(96)12976-1","article-title":"Novel receptor mechanisms for heroin and morphine-6\u03b2-glucuronide analgesia","volume":"216","author":"Rossi","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB50","first-page":"109","article-title":"Antisense mapping of MOR-1 in the rat: distinguishing between morphine and morphine-6\u03b2-glucuronide antinociception","volume":"281","author":"Rossi","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/5706","article-title":"Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1","volume":"2","author":"Schuller","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB53","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/0024-3205(82)90112-6","article-title":"Different receptors mediate morphine-induced prolactin and growth hormone release","volume":"31","author":"Spiegel","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB54","first-page":"293","article-title":"Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G-protein \u03b1 subunits","volume":"50","author":"Standifer","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB55","series-title":"Manual of Pharmacological Calculations with Computer Programs","author":"Tallarida","year":"1987"},{"key":"10.1016\/j.ejphar.2004.03.050_BIB56","first-page":"409","article-title":"Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice","volume":"218","author":"Umans","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0014-2999(82)90218-7","article-title":"Heroin: analgesia, toxicity and disposition in the mouse","volume":"85","author":"Umans","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(99)00633-0","article-title":"Antagonism of heroin and morphine self-administration in rats by the morphine-6\u03b2-glucuronide antagonist 3-O-methylnaltrexone","volume":"383","author":"Walker","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB59","first-page":"144","article-title":"The pharmacologic effects of heroin in relationship to its rate of biotransformation","volume":"129","author":"Way","year":"1960","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB60","first-page":"25","article-title":"Metabolism of heroin and its pharmacological implications","volume":"17","author":"Way","year":"1965","journal-title":"Bull. Narc."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB61","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/253448a0","article-title":"Differentiation of opiate agonist and antagonist receptor binding by protein-modifying reagents","volume":"256","author":"Wilson","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2004.03.050_BIB62","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1073\/pnas.78.10.6181","article-title":"Classification of multiple morphine and enkephalin binding sites in the central nervous system","volume":"78","author":"Wolozin","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2004.03.050_BIB63","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0014-5793(95)00028-8","article-title":"Cloning and expression of an isoform of the rat m opioid receptor (rMOR 1 B) which differs in agonist induced desensitization from rMOR1","volume":"359","author":"Zimprich","year":"1995","journal-title":"FEBS Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904003413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904003413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T13:24:33Z","timestamp":1549545873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904003413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":62,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0014299904003413"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.03.050","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}